Senators Press Trump Cabinet Members To Expand Marijuana Research Two separate bipartisan groups of U.S. senators sent letters to members of President Donald Trump’s Cabinet about expanding research on the medical benefits of marijuana on Thursday. One letter, sent to Robert Wilkie, the head of the U.S. Department of Veterans Affairs (VA), encouraged the department […]

Lawmakers in the Commonwealth of the Northern Mariana Islands (CNMI), a U.S. territory, have voted to send a marijuana legalization bill to the governor’s desk. The legislation, which was approved on by the CNMI Senate on Thursday by a vote of 6 – 0, with 2 abstentions, passed the House of Representatives earlier this month.

A Republican U.S. senator who earlier this year cut a deal with President Trump to support legislation ending federal cannabis prohibition is pushing back against news about White House plans to highlight “issues created by state marijuana initiatives.” As BuzzFeed first on Wednesday, the Trump administration has formed an entity called the Marijuana Policy Coordination Committee,

Patients suffering from epilepsy experience better health outcomes—with fewer adverse side effects—when they use plant-based cannabidiol (CBD) extracts compared to “purified” CBD products, according to a new scientific review. A team of Brazilian researchers conducted a meta-analysis of studies from 2013 to 2017 that have explored the therapeutic benefits of CBD for epilepsy patients. The

The move by the Drug Enforcement Administration (DEA) last week to dramatically increase the amount of marijuana that can be legally grown in the U.S. in 2019 for research purposes, combined with its decision to reduce opioid production levels, surprised longtime observers of the anti-narcotics agency. Now, in a new filing scheduled to be published in